PHS
BHVN icon

PFM Health Sciences’s Biohaven BHVN Stock Holding History

PFM Health Sciences’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-197,307
Closed -$4.74M – 61
2025
Q1 		$4.74M Sell
197,307
-234,609
-54% -$8.27M 0.34% 44
2024
Q4 		$16.1M Buy
+431,916
New +$20.2M 1% 32
2023
Q1 		– Sell
-10,988
Closed -$153K – 83
2022
Q4 		$153K Buy
+10,988
New +$155K 0.01% 88

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PFM Health Sciences's BHVN Position: Q2 2025 in Review

PFM Health Sciences sold out of Biohaven (BHVN) in Q2 2025, closing a stake of 197,307 shares — an estimated $4.74M sold.

PFM Health Sciences first reported a position in BHVN in Q4 2022 and held it in 3 quarters. The position peaked at $16.1M in Q4 2024. 249 funds tracked by Wall St. Rank hold BHVN as of Q2 2025.

  • PFM Health Sciences reported no remaining Biohaven position as of Q2 2025 after selling out during the quarter.
  • PFM Health Sciences sold 197,307 Biohaven shares in Q2 2025, an estimated $4.74M.
  • PFM Health Sciences first reported a position in Biohaven in Q4 2022 and held it in 3 quarters.
  • PFM Health Sciences's Biohaven position peaked at $16.1M in Q4 2024.
  • 249 funds tracked by Wall St. Rank held Biohaven as of Q2 2025.

Based on PFM Health Sciences's 13F filing for Q2 2025, filed 14 Aug 2025.